ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX)
CUSIP: 45256X103
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 1,124,549,707
- Total 13F shares
- 82,639,855
- Share change
- +13,882,576
- Total reported value
- $211,622,425
- Put/Call ratio
- 219%
- Price per share
- $2.56
- Number of holders
- 193
- Value change
- +$33,803,467
- Number of buys
- 100
- Number of sells
- 62
Quarterly Holders Quick Answers
What is CUSIP 45256X103?
CUSIP 45256X103 identifies IBRX - ImmunityBio, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45256X103:
Top shareholders of IBRX - ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
1.5%
|
16,902,516
|
$62,877,360 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
1.1%
|
11,857,531
|
$44,110,016 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.77%
|
8,654,460
|
$32,194,591 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.34%
|
3,846,675
|
$14,312,233 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.2%
|
2,246,892
|
$8,358,438 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.18%
|
2,069,780
|
$7,699,582 | — | 30 Sep 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.14%
|
1,544,802
|
$5,746,664 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.11%
|
1,288,907
|
$4,794,734 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.11%
|
1,265,981
|
$4,709,449 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.11%
|
1,226,076
|
$4,561,003 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.1%
|
1,140,911
|
$4,244,189 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.1%
|
1,116,765
|
$4,154,366 | — | 30 Sep 2024 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.07%
|
756,809
|
$2,815,329 | — | 30 Sep 2024 | |
| ALLEN HOLDING INC /NY |
13F
|
Company |
0.06%
|
687,571
|
$2,557,764 | — | 30 Sep 2024 | |
| SHEETS SMITH WEALTH MANAGEMENT |
13F
|
Company |
0.06%
|
665,995
|
$2,477,501 | — | 30 Sep 2024 | |
| Accurate Wealth Management, LLC |
13F
|
Company |
0.05%
|
560,000
|
$2,072,000 | — | 30 Sep 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.05%
|
520,053
|
$1,934,597 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.04%
|
505,321
|
$1,879,796 | — | 30 Sep 2024 | |
| Clearwater Capital Advisors, LLC |
13F
|
Company |
0.04%
|
482,549
|
$1,795,083 | — | 30 Sep 2024 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.04%
|
455,705
|
$1,695,223 | — | 30 Sep 2024 | |
| Corient Private Wealth LLC |
13F
|
Company |
0.04%
|
446,460
|
$1,660,832 | — | 30 Sep 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.04%
|
439,818
|
$1,636,123 | — | 30 Sep 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.04%
|
418,057
|
$1,555,172 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
0.04%
|
406,433
|
$1,511,930 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.04%
|
403,528
|
$1,501,124 | — | 30 Sep 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.03%
|
361,036
|
$1,343,053 | — | 30 Sep 2024 | |
| HARBOURVEST PARTNERS LLC |
13F
|
Company |
0.03%
|
335,709
|
$1,248,837 | — | 30 Sep 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.03%
|
333,519
|
$1,240,691 | — | 30 Sep 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.03%
|
316,110
|
$1,175,929 | — | 30 Sep 2024 | |
| John C. Thomas |
3/4/5
|
Former Director |
—
class O/S missing
|
216,363
|
$1,086,143 | — | 31 Dec 2021 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.02%
|
261,922
|
$1,029,354 | — | 30 Sep 2024 | |
| Skandinaviska Enskilda Banken AB (publ) |
13F
|
Company |
0.02%
|
270,950
|
$1,006,579 | — | 30 Sep 2024 | |
| Swiss National Bank |
13F
|
Company |
0.02%
|
270,000
|
$1,004,400 | — | 30 Sep 2024 | |
| Sculptor Capital LP |
13F
|
Company |
0.02%
|
217,800
|
$810,216 | — | 30 Sep 2024 | |
| Deutsche Girozentrale DekaBank |
13F
|
Individual |
0.02%
|
196,200
|
$782,000 | — | 30 Sep 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.02%
|
207,488
|
$771,843 | — | 30 Sep 2024 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0.02%
|
206,800
|
$769,296 | — | 30 Sep 2024 | |
| Clearstead Advisors, LLC |
13F
|
Company |
0.02%
|
206,000
|
$766,320 | — | 30 Sep 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.02%
|
205,530
|
$764,572 | — | 30 Sep 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.02%
|
194,442
|
$723,325 | — | 30 Sep 2024 | |
| Erste Asset Management GmbH |
13F
|
Company |
0.01%
|
153,000
|
$601,290 | — | 30 Sep 2024 | |
| LPL Financial LLC |
13F
|
Company |
0.01%
|
153,954
|
$572,709 | — | 30 Sep 2024 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.01%
|
135,029
|
$502,000 | — | 30 Sep 2024 | |
| China Universal Asset Management Co., Ltd. |
13F
|
Company |
0.01%
|
133,966
|
$498,354 | — | 30 Sep 2024 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.01%
|
131,324
|
$488,525 | — | 30 Sep 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.01%
|
131,364
|
$488,183 | — | 30 Sep 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
127,536
|
$475,000 | — | 30 Sep 2024 | |
| READYSTATE ASSET MANAGEMENT LP |
13F
|
Company |
0.01%
|
124,885
|
$464,572 | — | 30 Sep 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.01%
|
109,870
|
$408,716 | — | 30 Sep 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.01%
|
109,485
|
$407,284 | — | 30 Sep 2024 |
Institutional Holders of ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX) as of Q4 2024
As of 31 Dec 2024,
ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX) was held by
193 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
82,639,855 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., STATE STREET CORP, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, Woodline Partners LP, Cormorant Asset Management, LP, TANG CAPITAL MANAGEMENT LLC, UBS Group AG, and NORTHERN TRUST CORP.
This page lists
193
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
172
Q4 2024 holders
193
Holder diff
21
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.